Ischemic colitis, irritable bowel syndrome, and tegaserod--an alternative viewpoint
Pharmacotherapy
.
2005 Nov;25(11):1684-5; discussion 1685.
doi: 10.1592/phco.2005.25.11.1684.
Authors
Michael A Shetzline
1
,
Marielle Cohard-Radice
,
Bo Joelsson
Affiliation
1
Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936, USA. michael.shetzline@novartis.com
PMID:
16232032
DOI:
10.1592/phco.2005.25.11.1684
No abstract available
MeSH terms
Colitis, Ischemic / chemically induced*
Constipation / drug therapy
Humans
Indoles / adverse effects*
Irritable Bowel Syndrome / drug therapy*
Substances
Indoles
tegaserod